Kura Oncology, Inc. (FRA:KUR)
Germany
· Delayed Price · Currency is EUR 10.13
+0.04 (0.40%)
At close: Dec 5, 2025
Kura Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -216.88 | -173.98 | -152.63 | -135.84 | -130.47 | -89.63 | Upgrade
|
| Depreciation & Amortization | 0.83 | 0.85 | 0.85 | 0.76 | 0.56 | 0.19 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.99 | -13.14 | -9.42 | 1.61 | 4.39 | 0.41 | Upgrade
|
| Stock-Based Compensation | 34.39 | 33.9 | 28.08 | 26.32 | 23.58 | 12.81 | Upgrade
|
| Other Operating Activities | 0.55 | 0.52 | 0.48 | 0.07 | 0.61 | - | Upgrade
|
| Change in Accounts Receivable | -33.88 | - | - | - | - | - | Upgrade
|
| Change in Accounts Payable | 27.52 | 15.2 | 10.33 | -0.8 | -2.52 | 5.68 | Upgrade
|
| Change in Unearned Revenue | 317.61 | 278.18 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -32.34 | -7.21 | -2.51 | -2.18 | -0.71 | 0.71 | Upgrade
|
| Operating Cash Flow | 87.8 | 134.32 | -124.82 | -110.06 | -104.55 | -69.83 | Upgrade
|
| Capital Expenditures | -4.69 | -0.47 | -0.17 | -0.63 | -1.15 | -2.17 | Upgrade
|
| Investment in Securities | -38.77 | -101.12 | 15.73 | 33.25 | -125.69 | -97.77 | Upgrade
|
| Investing Cash Flow | -43.46 | -101.59 | 15.56 | 32.63 | -126.84 | -99.94 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 10 | - | - | Upgrade
|
| Total Debt Issued | - | - | - | 10 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -7.25 | -0.25 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 10 | -7.25 | -0.25 | Upgrade
|
| Issuance of Common Stock | 1.46 | 154.42 | 94.78 | 29.14 | 4.43 | 469.58 | Upgrade
|
| Other Financing Activities | - | - | - | -0.58 | -0.61 | - | Upgrade
|
| Financing Cash Flow | 1.46 | 154.42 | 94.78 | 38.57 | -3.44 | 469.33 | Upgrade
|
| Net Cash Flow | 45.81 | 187.14 | -14.48 | -38.87 | -234.82 | 299.57 | Upgrade
|
| Free Cash Flow | 83.11 | 133.85 | -124.99 | -110.69 | -105.7 | -72 | Upgrade
|
| Free Cash Flow Margin | 79.89% | 248.40% | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | 0.95 | 1.55 | -1.71 | -1.65 | -1.59 | -1.36 | Upgrade
|
| Cash Interest Paid | 1.1 | 1.1 | 1.06 | 0.07 | 0.78 | 0.42 | Upgrade
|
| Levered Free Cash Flow | -104.87 | -55.93 | -63.9 | -63.67 | -60.41 | -42.36 | Upgrade
|
| Unlevered Free Cash Flow | -103.89 | -54.92 | -62.93 | -63.53 | -60.15 | -41.99 | Upgrade
|
| Change in Working Capital | 278.9 | 286.17 | 7.82 | -2.98 | -3.22 | 6.38 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.